Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma

As diverse therapeutic options are now available for advanced melanoma patients, predictive markers that may assist treatment decision are needed. A model based on baseline serum lactate dehydrogenase (LDH), peripheral blood relative lymphocyte counts (RLC) and eosinophil counts (REC) and pattern of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Ferrucci, Pier Francesco, Gandini, Sara, Cocorocchio, Emilia, Pala, Laura, Baldini, Federica, Mosconi, Massimo, Antonini Cappellini, Gian Carlo, Albertazzi, Elena, Martinoli, Chiara
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668095/
https://ncbi.nlm.nih.gov/pubmed/29108362
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19748
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars